Polyvascular Disease Prevention Strategies
Explore secondary prevention strategies for polyvascular disease in peripheral vascular intervention patients. Learn about relevant financial disclosures, accreditation for continuing medical education, learning objectives, and commercial support. Claim CME and MOC points by the specified date.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Polyvascular Disease, Secondary Prevention in PVI Patients With PVD
Disclosures The faculty reported the following relevant financial relationships with commercial interests during the content development process for this activity: Nothing to report: Marc Bonaca, MD, MPH; Dharam Kumbhani, MD, FSCAI CME Oversight Committee reviewer Ronnie Ramadan, MD, FSCAI, reported no financial relationships. Ehrin Armstrong, MD, FSCAI. Consulting: Abbott Vascular, Boston Scientific, CSI, Medtronic, Philips, and PQ Bypass SCAI staff associated with the development of content for this activity, Robert Bartel, MSc, FACEHP, and Laura Daigle Porter, CMP, reported no relevant financial relationships. Sahil Parikh, MD, FSCAI. Ad Board: Abbott, Boston Scientific Corp, CSI, Medtronic. Consulting: Terumo, Merill Lifesciences , eFemoral. PI: Shockwave Medical, TriReme Medical, Surmodics.
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SCAI designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit . Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Evaluations, Certificates and ABIM MOC Evaluations are available on live.scai.org Please claim CME and MOC points by June 18, 2020
Learning Objectives Upon completion of this activity, participants will be able to: Describe the prevalence of atherosclerotic disease in more than one vascular bed and the associated cardiovascular outcomes for these patients. Identify best practices for medical therapy of patients with polyvascular disease. Individualize therapeutic strategies to meet the unique challenges of treating polyvascular disease in patients after revascularization.
Acknowledgement of Commercial Support This activity is supported by an unrestricted educational grant from Janssen No in-kind commercial support was received.
Agenda Antithrombotic Agents for Patients With PVD and After Peripheral Vascular Intervention Identification of Patients with PVD: Is There a Role for Screening or Systematic Identification? Marc P. Bonaca, MD, MPH Ehrin J. Armstrong, MD, FSCAI Combined Treatment of Coronary and Peripheral Artery Disease: Case Examples PSCK9 Inhibitors for Patients With PVD Dharam J. Kumbhani, MD, FSCAI Sahil A. Parikh, MD, FSCAI Panel Discussion
